Development and validation of a gene expression-based signature predicting efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter cohort study

MLA

Wei-Han Hu, et al. “Development and Validation of a Gene Expression-Based Signature Predicting Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Multicenter Cohort Study.” Journal of Clinical Oncology, vol. 38, May 2020, p. 6522. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........798c89ee9a9c53c9ad565a76653a32cf&authtype=sso&custid=ns315887.

APA

Wei-Han Hu, Na Liu, Ye-Lin Liang, Ya-Qin Wang, Yuan Zhang, Xu Liu, Yan Ping Mao, Wen-Xiu Ge, Ying Sun, Ling-Long Tang, Ying-Qin Li, Wen-Fei Li, Xiao-Hong Hong, Wei Jiang, Jun-Yan Li, Yuan Lei, Fangyun Xie, Lei Chen, Yu Pei Chen, & Jun Ma. (2020). Development and validation of a gene expression-based signature predicting efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter cohort study. Journal of Clinical Oncology, 38, 6522.

Chicago

Wei-Han Hu, Na Liu, Ye-Lin Liang, Ya-Qin Wang, Yuan Zhang, Xu Liu, Yan Ping Mao, et al. 2020. “Development and Validation of a Gene Expression-Based Signature Predicting Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Multicenter Cohort Study.” Journal of Clinical Oncology 38 (May): 6522. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........798c89ee9a9c53c9ad565a76653a32cf&authtype=sso&custid=ns315887.